Status:
COMPLETED
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III
Lead Sponsor:
Nanjing Medical University
Collaborating Sponsors:
The First Affiliated Hospital with Nanjing Medical University
Beijing Anzhen Hospital
Conditions:
Aortic Dissection
Eligibility:
All Genders
18-90 years
Brief Summary
Anatomopathological classifications have been well identified in aortic dissection with important therapeutic implications. The authors evaluated the inflammatory response in patients with aortic diss...
Eligibility Criteria
Inclusion
- acute type Aortic dissection;
Exclusion
- Iatrogenic aortic dissection OR traumatic aortic dissection
- Patients with hematological diseases, infectious diseases, malignant tumors, immune system diseases, or severe liver diseases.
- Preoperative use of mechanical ventilation, blood transfusion, renal replacement therapy, extracorporeal membrane oxygenation, or intra-aortic balloon pump during the current admission.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04918108
Start Date
January 1 2021
End Date
August 30 2021
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The first affiliated hospital of nanjing medical university
Nanjing, Jiangsu, China, 210029